Table 1. Baseline characteristics of patients with and without discharge statins.
Overall | No Statin | Statin | ||||||
---|---|---|---|---|---|---|---|---|
N = 13,024 | N = 1,983 | N = 11,078 | P value | |||||
Age (mean, SD) | 68 ±10.9 | 68 ±10.6 | 68.1±10.9 | 0.91 | ||||
Female | 2557 | 20.6% | 410 | 21.7% | 2147 | 20.4% | 0.23 | |
Body mass index (mean,SD) | 24.2 ±3.6 | 24.1 ±13.5 | 24.2±3.7 | 0.42 | ||||
Medical History | ||||||||
Myocardial infarction | 3062 | 24.6% | 452 | 23.9% | 2610 | 24.9% | 0.34 | |
Heart failure | 1101 | 8.9% | 170 | 9.0% | 931 | 8.9% | 0.9 | |
PCI | 4650 | 37.3% | 695 | 36.7% | 3955 | 37.6% | 0.45 | |
CABG | 672 | 5.5% | 96 | 5.1% | 576 | 5.5% | 0.47 | |
Diabetes mellitus | 5137 | 41.9% | 800 | 42.4% | 4337 | 41.5% | 0.64 | |
Chronic Kidney Disease | 3701 | 28.3% | 781 | 39.9% | 2920 | 26.6% | <0.001 | |
Hemodialysis | 578 | 4.4% | 76 | 4.0% | 502 | 4.8% | 0.14 | |
Cerebrovascular disease | 1108 | 8.5% | 177 | 9.4% | 931 | 8.9% | 0.51 | |
Peripheral vascular disease | 1040 | 8.0% | 163 | 8.6% | 877 | 8.4% | 0.75 | |
Chronic lung disease | 381 | 2.9% | 52 | 2.8% | 329 | 3.1% | 0.36 | |
Hypertension | 9268 | 70.9% | 1405 | 74.4% | 7863 | 75.2% | 0.44 | |
Smoking | 4181 | 32.0% | 624 | 33.1% | 3557 | 34.1% | 0.37 | |
Dyslipidemia | 8173 | 62.5% | 1239 | 65.7% | 6934 | 66.4% | 0.56 | |
Family history of CAD | 1440 | 11.0% | 223 | 11.9% | 1217 | 11.8% | 0.86 | |
Cancer | 487 | 3.7% | 68 | 3.8% | 419 | 4.1% | 0.45 | |
Cardiogenic shock | 552 | 4.2% | 86 | 4.3% | 466 | 4.2% | 0.81 | |
Acute coronary syndrome | 6022 | 46.1% | 923 | 46.5% | 5099 | 46.1% | 0.3 | |
Discharge medications | ||||||||
Aspirin | 12894 | 98.7% | 1912 | 96.1% | 10982 | 99.1% | <0.001 | |
Clopidogrel | 11924 | 91.2% | 1712 | 86.1% | 10212 | 92.2% | <0.001 | |
RAAS inhibitor | 8659 | 66.3% | 1136 | 57.1% | 7523 | 67.9% | <0.001 | |
Beta-blockers | 9166 | 70.1% | 1014 | 51.0% | 8152 | 73.6% | <0.001 | |
Warfarin | 1255 | 9.6% | 241 | 12.1% | 1014 | 9.2% | <0.001 |
Abbreviations: CAD; Coronary artery disease, SD; Standard deviation, PCI; Percutaneous coronary intervention, CABG; Coronary arterial bypass graft, LDL; Low-density lipoprotein, HDL; High-density lipoprotein, RAAS; Renin angiotensin aldosterone system